易于适应的生物传感器引导平台使除草剂代谢CYP2B6变体的选择成为可能
1The Robert H. Smith Institute of Plant Sciences and Genetics in Agriculture, The Hebrew University of Jerusalem, Rehovot 7610000, Israel.
ACS synthetic biology
|November 26, 2025
概括
我们开发了一种新的微生物系统,用于设计修改小分子的酶. 这个平台使用可进化的生物传感器将酶活性与细胞生长联系起来,加速生物催化剂的发展.
科学领域:
- 生物技术是生物技术.
- 合成生物学 合成生物学
- 酶工程是什么? 酶工程是什么?
背景情况:
- 由于缺乏可扩展的功能分析,阻碍了酶的定向进化.
- 将生物催化剂与微生物表型联系起来通常需要复杂的,定制的系统开发.
- 基因编码的生物传感器提供了一个模块化方法,将酶活性与可选择的表型联系起来.
研究的目的:
- 在统一的微生物框架内开发一个生物传感器进化和酶查的综合平台.
- 适应酵母双杂交系统,用于细胞染色体P450酶 (CYP) 的联合表达和查.
- 通过增强CYP2B6介导的除草剂阿拉克的代谢来证明平台的实用性.
主要方法:
- 使用酵母双混合平台与光激活细胞分类相结合.
- 采用PYRABACTIN RESISTANCE 1类受体和2C型蛋白酸酶作为一个可进化的生物传感器模块.
- 进行了四轮生物传感器引导进化,针对CYP2B6的表达和催化效率.
主要成果:
- 成功地适应了酵母双杂交系统用于CYP查.
- 孤立的生物传感器变种能够区分阿拉克及其代谢物.
- 通过定向进化实现了CYP2B6表达和催化效率的显著改善.
结论:
- 开发的平台集成了可进化的生物传感器和模块化菌株设计,以加速生物催化剂的开发.
- 该系统为设计小分子修饰酶,特别是CYP提供了强大的工具.
- 该方法通过将酶功能与可选择的微生物特征联系起来,便于创建定制生物催化剂.
相关概念视频
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
01:27Pharmacogenetics of Drug Metabolism: Overview
194
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
194
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
338
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
338
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
94
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
94
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
01:17Microbial Biosensors
88
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
88